#glp1 #obesityweek2025 #omadahealth #publichealth #behaviorscience Were excited to share our real-world evidence being presented at The Obesity Societys Obesity Week 2025 that demonstrated how Omada's program enhances outcomes for GLP-1 users: Increased persistence - with 84% still taking GLP-1s at 24 weeks 63.2% maintained or continued losing weight at 12 months after stopping medication Higher engagement led to 54% better odds of staying on medication These findings show that wraparound lifestyle support can make a significant difference in both medication persistence and long-term weight management
Browse all Peptides & GLP-1 education Consider this an independent editorial assessment
Spacing out injections (e.g., using it every 2-3 days instead of daily) can help your body adjust
Best Procedures for Loose Skin After GLP-1 Weight Loss Key Takeaways Quick GLP-1 fat loss typically results in loose skin as subcutaneous fat recedes more rapidly than skin can tighten, with sagging influenced by age, genetics, and weight loss volume
Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a position statement of the Fatty Liver Research Group of the Korean Diabetes Association
[2] Stephen D W S , Jamieson D J
